NUS logo

Nu Skin Enterprises (NUS) Stock

Profile

Country:

United States

IPO:

22 November 1996

Indexes:

Not included

Description:

Nu Skin Enterprises, Inc. is a marketing company that produces products that not only help you look young at any age, but most importantly, maintain your health. In 1984, three young people, striving to create fundamentally new skincare products, founded the company in Provo, Utah (USA). Currently, the company's brands Nu Skin and Pharmanex include over 200 premium class products. Specializing in cosmetics, personal hygiene, dietary supplements, and the most advanced skin care devices. Special attention is paid to developments in ageLOC (anti-aging technologies), body shaping, and weight management. The main trade marks include Nu Skin, Pharmanex, ageLOC, LifePak, Galvanic Spa, TR90, Epoch, ageLOC Me, and LumiSpa.

Key Details

Price

$7.26

TTM Dividend Yield

3.31%(-62.89% YoY)

Annual Revenue

$1.97 B(-11.53% YoY)

Annual EPS

$0.17(-91.79% YoY)

Beta

0.63

Events Calendar

Earnings

Next earnings date:

Feb 14, 2025

Recent quarterly earnings:

Nov 07, 2024

Recent annual earnings:

Feb 14, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Nov 29, 2024
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

22 Oct '24 Citigroup
Neutral
12 Aug '24 DA Davidson
Neutral
09 Aug '24 Citigroup
Neutral
09 May '24 DA Davidson
Neutral
05 Jan '24 DA Davidson
Neutral
16 Oct '23 Stifel
Hold
29 Sept '23 Citigroup
Neutral
03 Aug '23 DA Davidson
Neutral
02 Aug '23 Stifel
Hold
19 May '23 DA Davidson
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Vanity Stocks Nu-Skin (NUS), ULTA, HIMS Offer Upside Potential
Vanity Stocks Nu-Skin (NUS), ULTA, HIMS Offer Upside Potential
Vanity Stocks Nu-Skin (NUS), ULTA, HIMS Offer Upside Potential
NUS
seeitmarket.com25 November 2024

With such a great start to the holiday week, we could not help but gloat a little about the stocks I have mentioned related to the diet drugs, or what I call the “vanity” trade.

Nu Skin Enterprises (NUS) Lags Q3 Earnings and Revenue Estimates
Nu Skin Enterprises (NUS) Lags Q3 Earnings and Revenue Estimates
Nu Skin Enterprises (NUS) Lags Q3 Earnings and Revenue Estimates
NUS
zacks.com07 November 2024

Nu Skin Enterprises (NUS) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.56 per share a year ago.

FPT and National University of Singapore Join Forces in Driving AI Innovation and Fostering Talent Development
FPT and National University of Singapore Join Forces in Driving AI Innovation and Fostering Talent Development
FPT and National University of Singapore Join Forces in Driving AI Innovation and Fostering Talent Development
NUS
businesswire.com21 October 2024

SINGAPORE--(BUSINESS WIRE)--The National University of Singapore's School of Computing (NUS Computing) has entered into a partnership with FPT, a leading global technology corporation based in Vietnam, to advance the field of artificial intelligence (AI). This collaboration plans a joint investment of US$50 million, to be contributed by FPT, NUS, and other key players in the local and regional AI ecosystems over the next five years, aiming to drive pioneering research in AI and enhance talent d.

Nu Skin: Betting On A Potential Comeback
Nu Skin: Betting On A Potential Comeback
Nu Skin: Betting On A Potential Comeback
NUS
seekingalpha.com21 October 2024

Nu Skin Enterprises is at a potential inflection point with seemingly stabilized revenue. Management's restructuring and innovative product focus, particularly through the Rhyz business, show promise for a turnaround and long-term growth. A strong balance sheet and steady cash flow support the business, reducing bankruptcy risk and enabling strategic pivots and shareholder rewards.

NUS Stock Trading Below 200 & 50-Day SMA: What Should You Do Now?
NUS Stock Trading Below 200 & 50-Day SMA: What Should You Do Now?
NUS Stock Trading Below 200 & 50-Day SMA: What Should You Do Now?
NUS
zacks.com08 October 2024

Nu Skin is encountering persistent macroeconomic obstacles, weighing on consumer spending and customer acquisition.

Nu Skin Enterprises to Announce Third Quarter 2024 Financial Results
Nu Skin Enterprises to Announce Third Quarter 2024 Financial Results
Nu Skin Enterprises to Announce Third Quarter 2024 Financial Results
NUS
businesswire.com07 October 2024

PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release third quarter 2024 results after the market closes on Thursday, Nov. 7. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m. ET. During the call, management will discuss recent results and upcoming business initiatives. The webcast of the conference call, including the financial information presented, will be available on the investor.

Nu Skin Trading Near 52-Week Low: Should You Buy or Sell NUS Stock?
Nu Skin Trading Near 52-Week Low: Should You Buy or Sell NUS Stock?
Nu Skin Trading Near 52-Week Low: Should You Buy or Sell NUS Stock?
NUS
zacks.com23 September 2024

Nu Skin is facing macroeconomic difficulties and a slow-moving direct-selling market. Foreign currency headwinds are also weighing on NUS.

Mavely Achieves Major Milestones: $675M+ Run Rate with Increased Growth and Creator Payouts
Mavely Achieves Major Milestones: $675M+ Run Rate with Increased Growth and Creator Payouts
Mavely Achieves Major Milestones: $675M+ Run Rate with Increased Growth and Creator Payouts
NUS
prnewswire.com27 August 2024

Everyday Influencer Platform® Continues to Help Drive Sales at Scale for the World's Leading Brands CHICAGO , Aug. 27, 2024 /PRNewswire/ -- Mavely , the Everyday Influencer Platform®, today announces remarkable achievements, underscoring its position as a rapidly growing player in the influencer marketing industry. With incredible growth and significant financial milestones in the first half of 2024, Mavely continues its momentum to empower people to monetize their content by promoting the world's favorite brands.

Nu Skin (NUS) Down 28% in 3 Months: What's the Next Best Move?
Nu Skin (NUS) Down 28% in 3 Months: What's the Next Best Move?
Nu Skin (NUS) Down 28% in 3 Months: What's the Next Best Move?
NUS
zacks.com20 August 2024

Nu Skin (NUS) has been battling persistent macroeconomic headwinds, which have been weighing on consumer spending and customer acquisition. Strong currency headwinds are also playing foul.

Why Nu Skin Enterprises Stock Flopped on Friday
Why Nu Skin Enterprises Stock Flopped on Friday
Why Nu Skin Enterprises Stock Flopped on Friday
NUS
fool.com09 August 2024

The cosmetics purveyor released its latest set of quarterly results. It beat on both revenue and profitability, but investors were more concerned about the future.

FAQ

  • What is the primary business of Nu Skin Enterprises?
  • What is the ticker symbol for Nu Skin Enterprises?
  • Does Nu Skin Enterprises pay dividends?
  • What sector is Nu Skin Enterprises in?
  • What industry is Nu Skin Enterprises in?
  • What country is Nu Skin Enterprises based in?
  • When did Nu Skin Enterprises go public?
  • Is Nu Skin Enterprises in the S&P 500?
  • Is Nu Skin Enterprises in the NASDAQ 100?
  • Is Nu Skin Enterprises in the Dow Jones?
  • When was Nu Skin Enterprises's last earnings report?
  • When does Nu Skin Enterprises report earnings?
  • Should I buy Nu Skin Enterprises stock now?

What is the primary business of Nu Skin Enterprises?

Nu Skin Enterprises, Inc. is a marketing company that produces products that not only help you look young at any age, but most importantly, maintain your health. In 1984, three young people, striving to create fundamentally new skincare products, founded the company in Provo, Utah (USA). Currently, the company's brands Nu Skin and Pharmanex include over 200 premium class products. Specializing in cosmetics, personal hygiene, dietary supplements, and the most advanced skin care devices. Special attention is paid to developments in ageLOC (anti-aging technologies), body shaping, and weight management. The main trade marks include Nu Skin, Pharmanex, ageLOC, LifePak, Galvanic Spa, TR90, Epoch, ageLOC Me, and LumiSpa.

What is the ticker symbol for Nu Skin Enterprises?

The ticker symbol for Nu Skin Enterprises is NYSE:NUS

Does Nu Skin Enterprises pay dividends?

Yes, Nu Skin Enterprises pays dividends. The last payment was $0.06, with an ex-dividend date on 29 November 2024

What sector is Nu Skin Enterprises in?

Nu Skin Enterprises is in the Consumer Defensive sector

What industry is Nu Skin Enterprises in?

Nu Skin Enterprises is in the Household & Personal Products industry

What country is Nu Skin Enterprises based in?

Nu Skin Enterprises is headquartered in United States

When did Nu Skin Enterprises go public?

Nu Skin Enterprises's initial public offering (IPO) was on 22 November 1996

Is Nu Skin Enterprises in the S&P 500?

No, Nu Skin Enterprises is not included in the S&P 500 index

Is Nu Skin Enterprises in the NASDAQ 100?

No, Nu Skin Enterprises is not included in the NASDAQ 100 index

Is Nu Skin Enterprises in the Dow Jones?

No, Nu Skin Enterprises is not included in the Dow Jones index

When was Nu Skin Enterprises's last earnings report?

Nu Skin Enterprises's most recent earnings report was on 7 November 2024

When does Nu Skin Enterprises report earnings?

The next expected earnings date for Nu Skin Enterprises is 14 February 2025

Should I buy Nu Skin Enterprises stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions